Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer

NCT01413750 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

23

Enrollment

NIH

Sponsor class

Stopped CTEP Initiated Action

Conditions

Stage IIIA Lung Non-Small Cell Cancer AJCC v7
Stage IIIB Lung Non-Small Cell Cancer AJCC v7
Stage IV Lung Non-Small Cell Cancer AJCC v7

Interventions

DRUG: Carboplatin
OTHER: Laboratory Biomarker Analysis
DRUG: Paclitaxel
OTHER: Placebo Administration
DRUG: Vorinostat

Sponsor

National Cancer Institute (NCI)